体重指数与2019冠状病毒病及其他疾病死亡率:35506例ICU患者队列研究
调整混杂因素后,BMI≥35 kg/m2较正常体重者的院内死亡OR在COVID-19组为1.15(0.79-1.67),无统计学意义;在非SARS-CoV-2病毒性肺炎和细菌性肺炎组分别为0.64(0.43-0.95)和0.73(0.61-0.87),提示存在肥胖悖论。COVID-19患者男性更多、BMI更高、PaO2/FiO2更低、24小时内机械通气比例更高,ICU及住院时间更长,院内死亡率更高。结论:COVID-19相关呼吸衰竭的ICU患者中不存在肥胖悖论,与其他病毒性和细菌性呼吸道感染不同。
要点
- 在35506例ICU患者中,COVID-19组BMI≥35 kg/m2者院内死亡OR为1.15(0.79-1.67),与正常体重者无显著差异。
- 非SARS-CoV-2病毒性肺炎组BMI≥35 kg/m2的院内死亡OR为0.64(0.43-0.95),细菌性肺炎组为0.73(0.61-0.87),均提示肥胖悖论。
- 多发伤组BMI≥35 kg/m2的院内死亡OR为0.81(0.57-1.15),无统计学意义。
- COVID-19患者较其他队列男性更多、BMI更高、PaO2/FiO2更低、24小时内机械通气比例更高,ICU及住院时间更长,院内死亡率更高。
- 该研究为多中心观察性队列,不能推断因果关系;BMI与COVID-19患者ICU结局的关系需结合病情严重程度综合评估。
适用人群与场景
- 研究场景为ICU,不涉及院前或急诊科;纳入标准为ICU收治并登记于荷兰国家重症监护评估质量登记系统的患者。
诊断标准与关键阈值
- BMI分组以正常体重为参照,比较BMI≥35 kg/m2组与正常体重组的院内死亡风险。
处置流程与药物剂量
- 原文未提及任何药物剂量、给药途径、频次或治疗目标。
- 研究为观察性设计,无干预措施。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 主要终点为院内死亡率;调整混杂因素后,BMI≥35 kg/m2对比正常体重的院内死亡OR在COVID-19组为1.15(0.79-1.67),非SARS-CoV-2病毒性肺炎组为0.64(0.43-0.95),细菌性肺炎组为0.73(0.61-0.87),多发伤组为0.81(0.57-1.15)。
- COVID-19患者较其他队列男性更多、BMI更高、PaO2/FiO2更低、24小时内机械通气比例更高,ICU及住院时间更长,院内死亡率更高。
- 原文未提及关键次要终点的具体效应量及不良事件数据。
证据类型、等级与局限
- 证据类型为多中心观察性队列研究。
- 局限:观察性设计不能推断因果关系;原文未提及单中心、回顾性、开放标签或样本量局限。
对床旁实践的改变
- 在ICU的COVID-19呼吸衰竭患者中,不应依据BMI≥35 kg/m2单独判断院内死亡风险高低,因其与正常体重者无显著差异。
- 在非SARS-CoV-2病毒性肺炎和细菌性肺炎的ICU患者中,BMI≥35 kg/m2与较低的院内死亡风险相关,但为观察性结果,不能作为治疗决策依据。
- 该研究不改变现有ICU对COVID-19患者的常规监护和治疗流程;原文未提及适用或不适用人群的排除标准。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Obesity is a risk factor for severe coronavirus disease 2019 and might play a role in its pathophysiology. It is unknown whether body mass index is related to clinical outcome following ICU admission, as observed in various other categories of critically ill patients. We investigated the relationship between body mass index and inhospital mortality in critically ill coronavirus disease 2019 patients and in cohorts of ICU patients with non-severe acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and multiple trauma.
DESIGN: Multicenter observational cohort study.
SETTING: Eighty-two Dutch ICUs participating in the Dutch National Intensive Care Evaluation quality registry.
PATIENTS: Thirty-five-thousand five-hundred six critically ill patients.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patient characteristics and clinical outcomes were compared between four cohorts (coronavirus disease 2019, nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and multiple trauma patients) and between body mass index categories within cohorts. Adjusted analyses of the relationship between body mass index and inhospital mortality within each cohort were performed using multivariable logistic regression. Coronavirus disease 2019 patients were more likely male, had a higher body mass index, lower Pao2/Fio2 ratio, and were more likely mechanically ventilated during the first 24 hours in the ICU compared with the other cohorts. Coronavirus disease 2019 patients had longer ICU and hospital length of stay, and higher inhospital mortality. Odds ratios for inhospital mortality for patients with body mass index greater than or equal to 35 kg/m2 compared with normal weight in the coronavirus disease 2019, nonsevere acute respiratory syndrome coronavirus 2 viral pneumonia, bacterial pneumonia, and trauma cohorts were 1.15 (0.79-1.67), 0.64 (0.43-0.95), 0.73 (0.61-0.87), and 0.81 (0.57-1.15), respectively.
CONCLUSIONS: The obesity paradox, which is the inverse association between body mass index and mortality in critically ill patients, is not present in ICU patients with coronavirus disease 2019-related respiratory failure, in contrast to nonsevere acute respiratory syndrome coronavirus 2 viral and bacterial respiratory infections.
参考来源
- Kooistra EJ, Brinkman S, van der Voort PHJ, et al. Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. Crit Care Med. 2022. PMID: 34374504. doi:10.1097/CCM.0000000000005216
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。